CaseXCase Series
Validating AI’s transformative impact in biologics discovery and development
An in-depth collection of case studies showing how LensAI™ powered by HYFT® technology is driving transformation.
These studies demonstrate how AI supports more efficient discovery processes, uncovers complex biological insights, helps reduce development timelines, and informs decision-making across discovery and development.
Key study:
LensAI Epitope Mapping matches X-ray crystallography
CaseXCase Series
Epitope Mapping
Case study collection:
Key study:
LensAI Epitope Mapping retains near X-ray precision on ‘unseen’ diverse clinically relevant complexes
CaseXCase Series
Epitope Mapping
Key study:
LensAI prediction of Anti-Drug Antibody incidence: evidence for clinical utility of ADA risk assessment
CaseXCase Series
Immunogenicity
Key study:
Antibody engineering for tumor microenvironment targeting
CaseXCase Series
Tumor Micro
Environment
Inside the AI and lab ecosystem evolving discovery
Part of a broader ecosystem that brings together bio-native AI and advanced lab research, with a track record supporting 15+ molecules that have progressed to the clinic and greater than 98 percent success across B-cell discovery workflows.
Let’s discover what’s next. With award-recognized science and solution-driven services, we work with teams to help advance diverse, high-quality candidates toward the clinic.